The European Journal of Health Economics

Raw citation data, Impact Factor, Immediacy Index, Published documents, Citations received, , Most cited papers , Recent citations and documents published in this series in EconPapers.

Create citation feed for this series

Raw data:
IF AIF DOC CIT D2Y C2Y SC(%) CiY II AII 1996 0.18 0 0 0 0.08 1997 0.21 0 0 0 0.08 1998 0.22 0 0 0 0.1 1999 0.28 0 0 0 0.13 2000 0.37 0 0 0 0.16 2001 0.37 0 0 0 0.16 2002 0.41 0 0 0 0.19 2003 0.42 25 15 0 0 0.2 2004 0.04 0.47 65 20 25 1 0 0.21 2005 0.02 0.5 55 23 90 2 0 0.23 2006 0.07 0.51 63 38 120 8 12.5 1 0.02 0.22 2007 0.08 0.4 46 16 118 10 20 2 0.04 0.18 2008 0.11 0.42 57 14 109 12 25 1 0.02 0.21 2009 0.09 0.43 49 9 103 9 33.3 1 0.02 0.19
IF: Impact Factor: C2Y / D2Y AIF: Average Impact Factor for series in RePEc in year y DOC: Number of documents published in year y CIT: Number of citations to the series in year y D2Y: Number of articles published in y-1 plus y-2 C2Y: Cites in y to articles published in y-1 plus y-2 SC(%): Percentage of selft citations in y to articles published in y-1 plus y-2 CiY: Cites in year y to documents published in year y IdI: Immediacy Index: CiY / Documents.   AII: Average Immediacy Index for series in RePEc in year y
Impact Factor:	Immediacy Index:
Documents published:	Citations received:

Most cited documents in this series:

(1) RePEc:spr:eujhec:v:7:y:2006:i:1:p:7-18 The relationship between health care expenditure and health outcomes (2006).
Cited: 12 times.

(2) RePEc:spr:eujhec:v:8:y:2007:i:1:p:31-39 Risk-adjusted capitation payments: how well do principal inpatient diagnosis-based models work in the German situation? Results from a large data set (2007).
Cited: 5 times.

(3) RePEc:spr:eujhec:v:7:y:2006:i:3:p:204-211 Price regulation and generic competition in the pharmaceutical market (2006).
Cited: 5 times.

(4) RePEc:spr:eujhec:v:4:y:2003:i:4:p:248-253 Economic burden of obesity and its complications in Germany (2003).
Cited: 5 times.

(5) RePEc:spr:eujhec:v:6:y:2005:i:2:p:131-135 Spatial competition for quality in the market for hospital care (2005).
Cited: 4 times.

(6) RePEc:spr:eujhec:v:5:y:2004:i:2:p:150-165 An empirical analysis of the demand for physician services across the European Union (2004).
Cited: 4 times.

(7) RePEc:spr:eujhec:v:8:y:2007:i:3:p:195-212 Risk adjustment policy options for casemix funding: international lessons in financing reform (2007).
Cited: 4 times.

(8) RePEc:spr:eujhec:v:5:y:2004:i:2:p:166-174 Economic growth, longevity and the epidemiological transition (2004).
Cited: 3 times.

(9) RePEc:spr:eujhec:v:6:y:2005:i:3:p:233-243 An empirical analysis of tobacco addiction in Italy (2005).
Cited: 3 times.

(10) RePEc:spr:eujhec:v:7:y:2006:i:3:p:212-217 Alcohol-related mortality, drinking behavior, and business cycles (2006).
Cited: 3 times.

(11) RePEc:spr:eujhec:v:8:y:2007:i:3:p:297-300 Economic aspects of the new Spanish laws on pharmaceutical preparations (2007).
Cited: 3 times.

(12) RePEc:spr:eujhec:v:7:y:2006:i:1:p:37-45 Fixed budgets as a cost containment measure for pharmaceuticals (2006).
Cited: 3 times.

(13) RePEc:spr:eujhec:v:7:y:2006:i:4:p:285-289 Tests of stationarity and cointegration of health care expenditure and gross domestic product (2006).
Cited: 3 times.

(14) RePEc:spr:eujhec:v:7:y:2006:i:1:p:79-83 Off-patent drugs in Italy (2006).
Cited: 2 times.

(15) RePEc:spr:eujhec:v:6:y:2005:i:4:p:347-353 Estimating utility data from clinical indicators for patients with stable angina (2005).
Cited: 2 times.

(16) RePEc:spr:eujhec:v:10:y:2009:i:2:p:227-231 Factors affecting nurses’ decision to get the flu vaccine (2009).
Cited: 2 times.

(17) RePEc:spr:eujhec:v:6:y:2005:i:1:p:16-23 Modeling the economic burden of diseases imputable to stress at work (2005).
Cited: 2 times.

(18) RePEc:spr:eujhec:v:4:y:2003:i:3:p:176-183 Scale of reference bias and the evolution of health (2003).
Cited: 2 times.

(19) RePEc:spr:eujhec:v:7:y:2006:i:4:p:223-224 Time for a common standard for cost-effectiveness in Europe? (2006).
Cited: 2 times.

(20) RePEc:spr:eujhec:v:11:y:2010:i:6:p:595-596 On the welfare theoretic foundation of CEA: comment (2010).
Cited: 2 times.

(21) RePEc:spr:eujhec:v:9:y:2008:i:1:p:51-61 Work environment satisfaction and employee health: panel evidence from Denmark, France and Spain, 1994–2001 (2008).
Cited: 2 times.

(22) RePEc:spr:eujhec:v:11:y:2010:i:4:p:355-365 Optimal savings and health spending over the life cycle (2010).
Cited: 2 times.

(23) RePEc:spr:eujhec:v:11:y:2010:i:6:p:521-523 A French approach to cost-effectiveness analysis? (2010).
Cited: 2 times.

(24) RePEc:spr:eujhec:v:4:y:2003:i:4:p:263-270 Should one use smokeless tobacco in smoking cessation programs? (2003).
Cited: 2 times.

(25) RePEc:spr:eujhec:v:9:y:2008:i:4:p:405-416 Redistributive effects in public health care financing (2008).
Cited: 2 times.

(26) RePEc:spr:eujhec:v:10:y:2009:i:1:p:93-101 The quality of life of Palestinians living in chronic conflict: assessment and determinants (2009).
Cited: 2 times.

(27) RePEc:spr:eujhec:v:7:y:2006:i:2:p:114-116 Health care and patients’ migration across Spanish regions (2006).
Cited: 2 times.

(28) RePEc:spr:eujhec:v:7:y:2006:i:3:p:195-203 Determinants of household health expenditure on western institutional health care (2006).
Cited: 2 times.

(29) RePEc:spr:eujhec:v:11:y:2010:i:5:p:437-447 Health insurance for the poor: impact on catastrophic and out-of-pocket health expenditures in Mexico (2010).
Cited: 2 times.

(30) RePEc:spr:eujhec:v:10:y:2009:i:1:p:39-45 Comparing methodologies for the cost estimation of hospital services (2009).
Cited: 1 times.

(31) RePEc:spr:eujhec:v:5:y:2004:i:2:p:115-115 The risk-adjusted vision beyond casemix (DRG) funding in Australia (2004).
Cited: 1 times.

(32) RePEc:spr:eujhec:v:9:y:2008:i:4:p:311-312 Health technology assessment: for whom the bell tolls? (2008).
Cited: 1 times.

(33) RePEc:spr:eujhec:v:11:y:2010:i:3:p:255-266 The impact of missing data in the estimation of concentration index: a potential source of bias (2010).
Cited: 1 times.

(34) RePEc:spr:eujhec:v:5:y:2004:i:4:p:287-289 Using diagnosis-related groups (2004).
Cited: 1 times.

(35) RePEc:spr:eujhec:v:7:y:2006:i:4:p:265-269 The demand for private health care under national health insurance (2006).
Cited: 1 times.

(36) RePEc:spr:eujhec:v:11:y:2010:i:6:p:597-598 Cost-effectiveness analysis, welfare economics, and the societal perspective: a reply (2010).
Cited: 1 times.

(37) RePEc:spr:eujhec:v:8:y:2007:i:3:p:225-236 Variations in activity and practice patterns: a French study for GPs (2007).
Cited: 1 times.

(38) RePEc:spr:eujhec:v:4:y:2003:i:4:p:296-303 Project of Polish guidelines for conducting pharmacoeconomic evaluations in comparison to international health economic guidelines (2003).
Cited: 1 times.

(39) RePEc:spr:eujhec:v:9:y:2008:i:1:p:69-78 Willingness to pay for a reduction in mortality risk after a myocardial infarction: an application of the contingent valuation method to the case of eplerenone (2008).
Cited: 1 times.

(40) RePEc:spr:eujhec:v:7:y:2006:i:3:p:165-172 A decision model to compare health care costs of olanzapine and risperidone treatment for schizophrenia in Germany (2006).
Cited: 1 times.

(41) RePEc:spr:eujhec:v:11:y:2010:i:4:p:367-381 The challenge of corporatisation: the experience of Portuguese public hospitals (2010).
Cited: 1 times.

(42) RePEc:spr:eujhec:v:8:y:2007:i:1:p:59-65 A multilevel analysis on the determinants of regional health care expenditure: a note (2007).
Cited: 1 times.

(43) RePEc:spr:eujhec:v:8:y:2008:i:2:p:49-60 The burden of rheumatoid arthritis and access to treatment: health burden and costs (2008).
Cited: 1 times.

(44) RePEc:spr:eujhec:v:5:y:2004:i:2:p:110-115 Pricing of pharmaceuticals (2004).
Cited: 1 times.

(45) RePEc:spr:eujhec:v:9:y:2008:i:3:p:229-236 The cost of treating high blood pressure in general practice in France (2008).
Cited: 1 times.

(46) RePEc:spr:eujhec:v:11:y:2010:i:2:p:127-140 In which ways do unhealthy people older than 50 exit the labour market in France? (2010).
Cited: 1 times.

(47) RePEc:spr:eujhec:v:5:y:2004:i:3:p:270-273 Costs of treatment of colorectal cancer in different settings in Germany (2004).
Cited: 1 times.

(48) RePEc:spr:eujhec:v:6:y:2005:i:2:p:124-130 Validating the EQ-5D with time trade off for the German population (2005).
Cited: 1 times.

(49) RePEc:spr:eujhec:v:8:y:2007:i:3:p:213-223 Incorporating efficiency in hospital-capacity planning in Germany (2007).
Cited: 1 times.

(50) RePEc:spr:eujhec:v:4:y:2003:i:4:p:279-285 Financial incentives and the supply of laboratory tests (2003).
Cited: 1 times.

Recent citations received in: | 2009 | 2008 | 2007 | 2006

Recent citations received in: 2009

(1) RePEc:osk:wpaper:0917 Decision to get influenza vaccination: A behavioral economic approach (2009). Discussion Papers in Economics and Business

Recent citations received in: 2008

(1) RePEc:pra:mprapa:8280 Improving prevention compliance through appropriate incentives (2008). MPRA Paper

Recent citations received in: 2007

(1) RePEc:jns:jbstat:v:227:y:2007:i:5-6:p:485-501 Theorie und Praxis des Risikostrukturausgleichs (2007). Journal of Economics and Statistics (Jahrbuecher fuer Nationaloekonomie und Statistik)

(2) RePEc:spr:eujhec:v:8:y:2007:i:2:p:169-170 Comment on: Should we really worry about “launch delays” of new drugs in OECD countries? by L. Garatinni and S. Ghislandi (2007). The European Journal of Health Economics

Recent citations received in: 2006

(1) RePEc:spr:eujhec:v:7:y:2006:i:3:p:218-220 Decision models in the evaluation of psychotropic drugs (2006). The European Journal of Health Economics

Warning!! This is still an experimental service. The results of this service should be interpreted with care, especially in research assessment exercises. The processing of documents is automatic. There still are errors and omissions in the identification of references. We are working to improve the software to increase the accuracy of the results.

Source data used to compute the impact factor of RePEc series.